NDC 11673-704 - Multi Symptom Cold and Multi Symptom Nighttime Cold Childrens
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-704
- Package NDCs from labels
- 11673-704-04
- Manufacturer
- TARGET Corporation
- Effective date
- 2024-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Multi Symptom Cold Daytime Childrens - TARGET Corporation | TARGET Corporation | 2024-06-04 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-704-04 | Multi Symptom Cold and Multi Symptom Nighttime ColdChildrens | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 mL | 5 mg in 5mL | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-704 | MULTI SYMPTOM COLD AND MULTI SYMPTOM NIGHTTIME COLD CHILDRENS (DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI, ACETAMINOPHEN, DIPHENHYDRAMINE HCI, PHENYLEPHRINE HCI) KIT [TARGET CORPORATION] | 5 | Unmatched | 20240606_e3da3003-88e3-4431-8b65-e61e17728901.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| good sense pain relief | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 523b68da-cd2a-4960-95e7-de5d51ce33c1 | 2025-01-23 | Warnings | 362O9ITL9D |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | Caplin Steriles Limited | 1b3eec91-5be5-4010-bf92-4c3e72b39b2a | 2025-01-23 | Warnings, Adverse reactions | 04JA59TNSJ |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Direct_Rx | e78e50c0-36da-528e-e053-2995a90a3d80 | 2025-01-22 | Warnings, Adverse reactions | 362O9ITL9D |
| Tramadol Hydrochloride and Acetaminophen | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | Direct_Rx | e8a7c995-e473-ca87-e053-2995a90a5b80 | 2025-01-22 | Warnings, Adverse reactions | 362O9ITL9D |
| HYDROCODONE/APAP | HYDROCODONE/APAP | Direct_Rx | efe3b2eb-5c26-3783-e053-2995a90a6ba8 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Percocet | OXYCODONE/APAP | Direct_Rx | ee151649-b52a-0a51-e053-2a95a90a6c35 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Norco | HYDROCODONE/APAP | Direct_Rx | ee248dfd-7aa7-7dcc-e053-2995a90af19f | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone/APAP | HYDROCODONE/APAP | Direct_Rx | f0e66441-668a-7ab8-e053-2995a90aba4f | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Childrens Allergy Relief | DIPHENHYDRAMINE HCL | Best Choice | 0035e6a4-b3ef-4e0b-aa7f-7453dd065f4d | 2025-01-22 | Warnings | M012 TC2D6JAD40 |
| OASIS Tears Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 00071697-4ac6-4962-8eee-388b8b52bd40 | 2025-01-22 | Warnings | PDC6A3C0OX |
| GOOD REMEDIES Allergy Relief SOFTGEL | DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 26a02737-2cfd-769f-e063-6394a90af352 | 2025-01-22 | Warnings | M012 TC2D6JAD40 |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | 1Q73Q2JULR | |
| OASIS Tears Plus Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | ea931c0f-c61e-4771-84f1-0274b1c3e28e | 2025-01-22 | Warnings | PDC6A3C0OX |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | 1Q73Q2JULR |
| PHARBEDRYL | DIPHENHYDRAMINE HCL 50MG | Ulai Health LLC | 135293fb-5674-4638-be55-b968cf51257e | 2025-01-20 | Warnings | TC2D6JAD40 |
| Pharbetol | ACETAMINOPHEN 325 MG | Ulai Health LLC | 55bb7e6c-e98c-48bd-b7bb-9848ff0273ca | 2025-01-20 | Warnings | 362O9ITL9D |
| Pharbechlor | CHLORPHENIRAMINE MALEATE 4MG | Ulai Health LLC | 6a1a5cef-e946-4ba8-9402-557c6adf45f9 | 2025-01-20 | Warnings | M012 |
| ACETAMINOPHEN PM | ACETAMINOPHEN 500MG / DIPHENHYDRAMINE HCL 25MG | Ulai Health LLC | d4a568c9-a721-48d1-aebc-fc65444947ce | 2025-01-20 | Warnings | TC2D6JAD40 362O9ITL9D |
| Pharbinex | GUAIFENESIN 400MG | Ulai Health LLC | 4eafa81a-aeee-4c97-85d6-594902b10919 | 2025-01-20 | M012 495W7451VQ | |
| Pharbinex-PE | GUAIFENESIN 400MG AND PHENYLEPHRINE HCL 10MG | Ulai Health LLC | e459bb83-b1d6-42fc-aa46-99ad117e6144 | 2025-01-20 | M012 04JA59TNSJ 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.